Skip to main content
OpenTrials
Completed

NCT Number: NCT05113303

COREV 2.0 PMCF-Study on Manual and Navigated Revision Knee Patients

The Columbus® Revision endoprosthetic system is bearing the CE-mark. This means that within the scope of this observational study the patient will not be subjected to any additional stressful, study-related medical examinations or treatment measures. The treatment will be carried out exclusively according to medical standards. The study therefore only serves the purpose of observing this standard-compliant treatment and specifically documenting it scientifically.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The study's main purpose is the collection of clinical data on the safety and performance of the Columbus® Revision Knee endoprosthesis

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient underwent navigated revision surgery using the Columbus® Revision knee prosthesis (case group)
  • Patient underwent conventional manual revision surgery using another implant system (control group)
  • Written informed consent

Exclusion criteria

  • Pregnancy
  • Patient Age at time of revision surgery < 18 years
  • Allergy to any prosthesis component

Treatment and study plan

Navigated Revision Total Knee Arthroplasty

Device

Patients in the case group receive a Columbus® Revision knee prosthesis, implanted with computer assisted surgery

Manual Revision Total Knee Arthroplasty

Device

Patients in the control group will correspond to a historical cohort of patients in which manual jig-assisted knee revision was done.

Primary outcomes

  1. Compare the final joint line height between groups after the surgical restoration of native joint line height of revision implants

    Time frame: Comparison of final joint line height before the surgery with height at the 3 months follow-up

    Joint line height will be assessed using the systematic, comparative x-ray analysis

Secondary outcomes

  1. Maintenance of Hip knee Ankle Angle

    Time frame: Comparison of HKA before the surgery with HKA at 3 months and 2 years follow-up

    The HKA within 3 degrees of neutral has been used as the essential outcome measure in TKA.

  2. Forgotten Joint Score

    Time frame: At final follow-up at least 2 years after surgery

    The FJS Knee was designed to assess patient outcome in patients undergoing conservative or operative treatment of the knee. These PRO questionnaires focus on patients' awareness of a specific joint in everyday life. In 12 Items the awareness for the artificial joint is assessed by the patient, each on a five point scale (Never / Almost Never / Seldom / Sometimes / Mostly)

  3. WOMAC Score

    Time frame: At final follow-up at least 2 years after surgery

    The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a widely used, proprietary set of standardized questionnaires used by health professionals to evaluate the condition of patients with osteoarthritis of the knee and hip, including pain (5 items), stiffness (2 items), and physical functioning (17 items) of the joints. Each item is assessed by the patient on a five point scale (none / slight / moderate / severe / extreme)

  4. KSS Score

    Time frame: At final follow-up at least 2 years after surgery

    The KSS is an examiner--administrated standard clinical evaluation tool reporting results for patients undergoing TKA. It separates findings in the operated knee (kKSS) score from findings related to the patient's function (fKSS), which might be affected by co-morbidities. The two sub-scores are reported separately ranging from 0 points (worst result) to 100 points (best results), as well as summarized score, total KSS. Final grading of total KSS results Scores of 160 to 200 will be rated as excellent, 140 to 159 as good, 120 to 139 as fair, and less than 120 as poor.

  5. Implant survival

    Time frame: Until final follow-up at least 2 years after surgery

    Survival in the sense of this study is defined as a removal or exchange of any revision implant components including the removal or exchange of the PE meniscus component. Secondary interventions at the index knee e.g. secondary patella replacement do not count as a revision if no further exchange of the former implant components occur.

    The revision-free survival rate is the performance indicator of the product under investigation and confirms the clinical outcome of the knee prosthesis. Information on survival of the implant will be collected until the last follow-up of the study patients took place.

  6. Documentation of Adverse events/serious adverse events

    Time frame: over the whole course of the study from surgery until final follow-up at least 2 years after surgery

    During the course of the study, any upcoming intra- or postoperative (serious) adverse device events or effects related or not related to the product under investigation, will be documented in the dedicated Case Report Forms The total number of AEs will be summarized and further evaluated by the sponsor Recorded complications will be categorized and analyzed in order to assess the safety of the investigational product

Other outcomes

  1. Descriptive analysis of Radiological assessment

    Time frame: from discharge until final follow-up at least 2 years after surgery

    All follow-up imaging exams will be obtained according to the radiographic protocol of the hospital and the set routine. Imaging will be used to evaluate the implant status as well as device condition and potential presence of device-related Adverse Events including fracture, wear, loosening or radiolucencies, as well as the parameters of joint line restoration, rotational alignment and posterior condylar offset.

Sponsors and collaborators

Lead sponsor

Aesculap AG

Industry

Collaborators

  • B.Braun Surgical SA

Registry information

Official study title

Comparative, Case Control, Mono-center PMCF Study on Manual and Navigated Revision Knee Patients After a Minimum Follow-Up of Two Years

Acronym: COREV

Important dates

Study start
2022
Primary completion
2023
Study completion
2024
First posted
Nov 9, 2021
Registry last updated
Aug 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.